Literature DB >> 31315512

Brain fibrinogen deposition plays a key role in MS pathophysiology - Yes.

Dimitrios Davalos1, Kedar R Mahajan1,2, Bruce D Trapp1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31315512      PMCID： PMC6750992          DOI： 10.1177/1352458519852723

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  10 in total

1.  Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?

Authors:  Christina Marik; Paul A Felts; Jan Bauer; Hans Lassmann; Kenneth J Smith
Journal:  Brain       Date:  2007-11       Impact factor: 13.501

Review 2.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

3.  Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.

Authors:  May H Han; Sun-Il Hwang; Dolly B Roy; Deborah H Lundgren; Jordan V Price; Shalina S Ousman; Guy Haskin Fernald; Bruce Gerlitz; William H Robinson; Sergio E Baranzini; Brian W Grinnell; Cedric S Raine; Raymond A Sobel; David K Han; Lawrence Steinman
Journal:  Nature       Date:  2008-02-17       Impact factor: 49.962

4.  Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.

Authors:  Marco Vercellino; Silvia Masera; Marcella Lorenzatti; Cecilia Condello; Aristide Merola; Alessandra Mattioda; Antonella Tribolo; Elisabetta Capello; Giovanni Luigi Mancardi; Roberto Mutani; Maria Teresa Giordana; Paola Cavalla
Journal:  J Neuropathol Exp Neurol       Date:  2009-05       Impact factor: 3.685

5.  Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex.

Authors:  Richard L Yates; Margaret M Esiri; Jacqueline Palace; Benjamin Jacobs; Rafael Perera; Gabriele C DeLuca
Journal:  Ann Neurol       Date:  2017-08-19       Impact factor: 10.422

6.  The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease.

Authors:  Ryan A Adams; Jan Bauer; Matthew J Flick; Shoana L Sikorski; Tal Nuriel; Hans Lassmann; Jay L Degen; Katerina Akassoglou
Journal:  J Exp Med       Date:  2007-03-05       Impact factor: 14.307

7.  Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation.

Authors:  Jae Kyu Ryu; Mark A Petersen; Sara G Murray; Kim M Baeten; Anke Meyer-Franke; Justin P Chan; Eirini Vagena; Catherine Bedard; Michael R Machado; Pamela E Rios Coronado; Thomas Prod'homme; Israel F Charo; Hans Lassmann; Jay L Degen; Scott S Zamvil; Katerina Akassoglou
Journal:  Nat Commun       Date:  2015-09-10       Impact factor: 14.919

8.  Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration.

Authors:  Jae Kyu Ryu; Victoria A Rafalski; Anke Meyer-Franke; Ryan A Adams; Suresh B Poda; Pamela E Rios Coronado; Lars Østergaard Pedersen; Veena Menon; Kim M Baeten; Shoana L Sikorski; Catherine Bedard; Kristina Hanspers; Sophia Bardehle; Andrew S Mendiola; Dimitrios Davalos; Michael R Machado; Justin P Chan; Ioanna Plastira; Mark A Petersen; Samuel J Pfaff; Kenny K Ang; Kenneth K Hallenbeck; Catriona Syme; Hiroyuki Hakozaki; Mark H Ellisman; Raymond A Swanson; Scott S Zamvil; Michelle R Arkin; Stevin H Zorn; Alexander R Pico; Lennart Mucke; Stephen B Freedman; Jeffrey B Stavenhagen; Robert B Nelson; Katerina Akassoglou
Journal:  Nat Immunol       Date:  2018-10-15       Impact factor: 25.606

Review 9.  Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics.

Authors:  Mark A Petersen; Jae Kyu Ryu; Katerina Akassoglou
Journal:  Nat Rev Neurosci       Date:  2018-04-05       Impact factor: 34.870

10.  Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.

Authors:  Dimitrios Davalos; Jae Kyu Ryu; Mario Merlini; Kim M Baeten; Natacha Le Moan; Mark A Petersen; Thomas J Deerinck; Dimitri S Smirnoff; Catherine Bedard; Hiroyuki Hakozaki; Sara Gonias Murray; Jennie B Ling; Hans Lassmann; Jay L Degen; Mark H Ellisman; Katerina Akassoglou
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919
  10 in total
  4 in total

1.  Neuroinflammatory disease disrupts the blood-CNS barrier via crosstalk between proinflammatory and endothelial-to-mesenchymal-transition signaling.

Authors:  Zhonglou Sun; Helong Zhao; Daniel Fang; Chadwick T Davis; Dallas S Shi; Kachon Lei; Bianca E Rich; Jacob M Winter; Li Guo; Lise K Sorensen; Robert J Pryor; Nina Zhu; Samuel Lu; Laura L Dickey; Daniel J Doty; Zongzhong Tong; Kirk R Thomas; Alan L Mueller; Allie H Grossmann; Baowei Zhang; Thomas E Lane; Robert S Fujinami; Shannon J Odelberg; Weiquan Zhu
Journal:  Neuron       Date:  2022-08-11       Impact factor: 18.688

2.  Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis.

Authors:  Ellen F Mosleth; Christian Alexander Vedeler; Kristian Hovde Liland; Anette McLeod; Gerd Haga Bringeland; Liesbeth Kroondijk; Frode Steingrimsen Berven; Artem Lysenko; Christopher J Rawlings; Karim El-Hajj Eid; Jill Anette Opsahl; Bjørn Tore Gjertsen; Kjell-Morten Myhr; Sonia Gavasso
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

Review 3.  Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.

Authors:  Mohamed S Abdel-Bakky; Elham Amin; Mohamed G Ewees; Nesreen I Mahmoud; Hamdoon A Mohammed; Waleed M Altowayan; Ahmed A H Abdellatif
Journal:  Viruses       Date:  2022-01-24       Impact factor: 5.048

4.  Analysis of CSF D-Dimer to Identify Intrathecal Fibrin-Driven Autoimmunity in Patients With Multiple Sclerosis.

Authors:  Martin A Schaller-Paule; Yavor Yalachkov; Helmuth Steinmetz; Lucie Friedauer; Elke Hattingen; Wolfgang Miesbach; Frank Weber; Konstantin Kirchmayr; Jan Hendrik Schaefer; Christian Foerch
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.